Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151513 · ClinicalTrials.gov registry record
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
A clinical trial of Cancer Associated Pain, sponsored by University of Utah.
- Completed
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT02151513 is a study of Cancer Associated Pain that has completed, run by University of Utah. The registered enrollment target is 51 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02151513, a study of Cancer Associated Pain, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little alteration of immune function as measured by biomarkers in the blood of cancer patients with moderate to severe pain.
Conditions Studied
Interventions
- DEVICE Intrathecal Pump Placement
Study Locations (1)
Utah
- Huntsman Cancer Hosptial - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2018-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02151513
The ClinicalTrials.gov registry entry for NCT02151513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer Associated Pain appearing as the primary indexed condition, and to 1 intervention - of which Intrathecal Pump Placement is the first listed.
NCT02151513 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT02151513 about?
NCT02151513 is a clinical study titled "Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain". The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy i...
What is the current status of trial NCT02151513?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2014-04-01. Estimated completion is 2018-06-01.
What conditions does trial NCT02151513 study?
This clinical trial studies the following conditions: Cancer Associated Pain.
What interventions are being tested in trial NCT02151513?
The interventions under investigation include: Intrathecal Pump Placement (DEVICE).
Who is sponsoring clinical trial NCT02151513?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02151513 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Associated Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.